Aminoterminal B-type Pro-Natriuretic Peptide as a Marker of Recovery After High-risk Coronary Artery Bypass Grafting in Patients With Ischemic Heart Disease and Severe Impaired Left Ventricular Function

Journal of Heart and Lung Transplantation

Volumn 25, Issue 5, 2006, Pages 596-602

  Rothenburger, M ^a   Stypmann, J ^a   Bruch, C ^a   Wichter, T ^a   Hoppe, M ^a   Drees, G ^a   Berendes, E ^a   Huelsken, G ^a   Loeher, A ^a   Welp, H ^a   Rottger C ^a   Schmid, C ^a   Scheld, H H ^a   Tjan, T D T ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERGOMETRY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ARTERY BYPASS; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; RECOVERY OF FUNCTION; SPIROMETRY; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33646144869     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.12.006     Document Type: Article

References (29)

1. Lloyd-Jones D.M. The risk of congestive heart failure. sobering lessons from the Framingham Heart Study. Curr Card Rep 3 (2001) 184-190
2. Pitt B., Zannad F., Remme W.J., et al., Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
3. Elefteriades J., and Edwards R. Coronary bypass in left heart failure. Sem Thorac Cardiovasc Surg 14 (2002) 125-132
4. Starling R.C. Introduction. cardiac surgery for heart failure. Sem Thorac Cardiovasc Surg 14 (2002) 122-124
5. Kay G.L., Sun G.W., Aoki A., and Prejean C.A. Influence of ejection fraction on hospital mortality, morbidity, and costs for CABG patients. Ann Thorac Surg 60 (1995) 1640-1651
6. Mitropoulos F.A., and Elefteriades J.A. Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction. Heart Fail Rev 6 (2001) 163-175
7. Luciani G.B., Faggian G., Razzolini R., et al. Severe ischemic left ventricular failure. coronary operation or heart transplantation?. Ann Thorac Surg 55 (1993) 719-723
8. Shum-Tim D., Pelletier M.P., Latter D.A., DeVarennes B.E., and Morin J.E. Transplantation versus coronary artery bypass grafting in patients with severe ventricular dysfunction. Surgical outcome and quality of life. J Cardiovasc Surg 40 (2000) 773-780
9. Carr J.A., Haithcock B.E., Paone G., Bernabei A.F., and Silverman N.A. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg 74 (2002) 1531-1536
10. Mickleborough L.L., Carson S., Tamariz M., and Ivanov J. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 119 (2000) 550-557
11. Mangano D.T., and Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
12. Billing J.S., Ooi A., and Large S.R. The outcome of cardiac surgery in high-risk quaternary referral patients. Interact Cardiovasc Thorac Surg 2 (2003) 369-372
13. Rothenburger M., Wichter T., Schmid C., et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23 (2004) 1189-1197
14. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
15. DeLemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
16. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
17. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
18. Tjan T.D., Kondruweit M., Scheld H.H., et al. The bad ventricle-revascularization versus transplantation. Thorac Cardiovasc Surg 48 (2000) 9-14
19. Jones E.L., Craver J.M., Kaplan J.A., et al. Criteria for operability and reduction of surgical mortality in patients with severe left ventricular ischemia and dysfunction. Ann Thorac Surg 25 (1978) 413-424
20. Pasini E., Ferrari G., Cremona G., and Ferrari M. Revascularization of severe hibernating myocardium in the beating heart. early hemodynamic and metabolic features. Ann Thorac Surg 71 (2001) 176-179
21. Bouchart F., Tabley A., Litzler P.Y., et al. Myocardial revascularization in patients with severe ischemic left ventricular dysfunction. Long term follow-up in 141 patients. Eur J Cardiothorac Surg 20 (2001) 1157-1162
22. Arakawa N., Nakumara M., Aoki H., and Hiramori K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85 (1994) 334-340
23. Horio T., Shimada K., Kohno M., et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 126 (1993) 293-299
24. Nagaya N., Nishikimi T., Goto Y., et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 135 (1998) 21-28
25. Richards A.M., Nicholls M.G., Yandle T.G., et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 81 (1999) 114-120
26. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. correlation with left ventricular systolic dysfunction. Eur Heart J 21 (2000) 1514-1521
27. Darbar D., Davidson N.C., Gillespie N., et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78 (1996) 284-287
28. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after acute myocardial infarction. comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
29. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564